Müller, B. et al. (2024) “Severe cutaneous toxicity in a 67-year-old patient with metastatic urothelial carcinoma undergoing therapy with enfortumab vedotin and pembrolizumab”, European Journal of Case Reports in Internal Medicine, 11(12). doi:10.12890/2024_005003.